News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,435 Results
Type
Article (86481)
Company Profile (702)
Press Release (759252)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232676)
Career Advice (4127)
Deals (39719)
Drug Delivery (129)
Drug Development (90982)
Employer Resources (198)
FDA (18106)
Job Trends (17334)
News (396451)
Policy (39746)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56832)
ALS (99)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (157)
Approvals (18068)
Artificial intelligence (329)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (304)
Cancer (2452)
Cardiovascular disease (206)
Career advice (3534)
Career pathing (34)
CAR-T (174)
Cell therapy (494)
Cervical cancer (21)
Clinical research (73409)
Collaboration (915)
Company closure (1)
Compensation (567)
Complete response letters (30)
COVID-19 (2868)
CRISPR (48)
C-suite (266)
Cystic fibrosis (107)
Data (2284)
Decentralized trials (2)
Denatured (45)
Depression (56)
Diabetes (299)
Diagnostics (6922)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (128)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96695)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130049)
Executive appointments (779)
FDA (19454)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (819)
Gene editing (120)
Generative AI (35)
Gene therapy (359)
GLP-1 (855)
Government (5160)
Grass and pollen (6)
Guidances (75)
Healthcare (20886)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (3029)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (812)
IPO (17816)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (559)
Leadership (24)
Legal (10113)
Liver cancer (82)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (354)
MASH (76)
Medical device (14639)
Medtech (14644)
Mergers & acquisitions (22445)
Metabolic disorders (793)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2110)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (426)
Opinion (275)
Ovarian cancer (79)
Pain (99)
Pancreatic cancer (88)
Parkinson's disease (161)
Partnered (24)
Patents (251)
Patient recruitment (116)
Peanut (51)
People (65304)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22656)
Phase II (31869)
Phase III (24016)
Pipeline (1265)
Policy (173)
Postmarket research (3552)
Preclinical (10223)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (430)
Real estate (7392)
Recruiting (75)
Regulatory (26802)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (30)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (47)
The Weekly (82)
Vaccines (815)
Venture capitalists (44)
Weight loss (305)
Women's health (40)
Worklife (20)
Date
Today (129)
Last 7 days (979)
Last 30 days (2789)
Last 365 days (35794)
2025 (11974)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50135)
Australia (8831)
California (6480)
Canada (2075)
China (564)
Colorado (284)
Connecticut (303)
Delaware (160)
Europe (114992)
Florida (946)
Georgia (221)
Hawaii (1)
Idaho (64)
Illinois (633)
India (31)
Indiana (336)
Iowa (12)
Japan (171)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (972)
Massachusetts (4962)
Michigan (249)
Minnesota (423)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1833)
New Mexico (31)
New York (1839)
North Carolina (1134)
North Dakota (9)
Northern California (2767)
Ohio (220)
Oklahoma (15)
Oregon (48)
Pennsylvania (1426)
Puerto Rico (13)
Rhode Island (36)
South America (1652)
South Carolina (24)
South Dakota (1)
Southern California (2402)
Tennessee (105)
Texas (973)
United States (24892)
Utah (193)
Virginia (172)
Washington D.C. (70)
Washington State (607)
West Virginia (3)
Wisconsin (70)
There are 846,435 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
BMS Axes 516 More Employees in New Jersey
Bristol Myers Squibb has made significant cuts to its workforce since last year as part of a strategic reorganization aimed at saving $3.5 billion through 2027. The latest cuts in Lawrenceville, New Jersey, bring that area’s total number of disclosed cuts this year to 806.
May 5, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Optimi Health Obtains U.S. FDA Drug Establishment Registration
The Company is now recognized by the U.S. FDA to support the cross-border supply of GMP MDMA and psilocybin to authorized entities in the United States.
May 5, 2025
·
6 min read
Press Releases
Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
May 5, 2025
·
12 min read
Press Releases
Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
May 5, 2025
·
6 min read
Earnings
BioNTech’s Ambitious PD-L1/VEGF Plans Currently Rely on Chinese Manufacturing
BNT327, a PD-L1/VEGF therapy, is still currently being manufactured in China, but BioNTech is working to establish a diversified supply chain, executives said during the company’s Q1 investor call.
May 5, 2025
·
3 min read
·
Tristan Manalac
Layoff Tracker
Pliant Cuts 45% of Staff To Extend Cash Runway
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 5, 2025
·
187 min read
·
BioSpace Editorial Staff
Press Releases
Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1
May 5, 2025
·
5 min read
Press Releases
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025
May 5, 2025
·
2 min read
Press Releases
Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision
May 5, 2025
·
13 min read
Press Releases
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
May 5, 2025
·
5 min read
1 of 84,644
Next
